You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1612 Results
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - In Combination with Carboplatin and Paclitaxel for First-Line Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
PACLitaxel,
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2022
Drug
Other Name(s): Cabometyx®
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2025
Guidelines and Advice
Status: Current
ID: GL 3-20
Version: N/A
Aug 2019
*/
Document
Aug 2019
Document
Aug 2019
Document
Aug 2019
Document
Aug 2019
Document
Aug 2019

Pages